Efficacy and safety of transvaginal mesh repair in a cohort with a minimum of 10-year follow-up

被引:0
作者
Zhibo Zhang
Jianbin Guo
Weijie Tian
Ye Zhang
Yuelun Zhang
Tianshu Sun
Jiali Duan
Xinmiao Bao
Yuan Wang
Yang Ye
Qianqian Gao
Honghui Shi
Abraham Nick Morse
Juan Chen
Lan Zhu
机构
[1] National Clinical Research Center for Obstetric and Gynecologic Diseases,Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
[2] Medical College of Guizhou University,Department of Gynecology, Guizhou Provincial People’s Hospital
[3] The First Affiliated Hospital of Zhengzhou University,Department of Obstetrics and Gynecology
[4] Chinese Academy of Medical Sciences & Peking Union Medical College,Medical Research Center, Peking Union Medical College Hospital
[5] Chinese Academy of Medical Sciences & Peking Union Medical College,Medical Doctor Program
[6] Peking Union Medical College Hospital,Department of Pathology
[7] Tufts University School of Medicine,undefined
来源
Science China Life Sciences | 2024年 / 67卷
关键词
complication; efficacy; long-term follow-up; pelvic organ prolapse; safety; transvaginal mesh;
D O I
暂无
中图分类号
学科分类号
摘要
Although transvaginal mesh (TVM) repair is no longer used in some countries, long-term outcomes after TVM surgery are of great importance globally. However, reports with follow-up >10 years are limited. Thus, this study aimed to report outcomes in a prospective cohort with at least 10 years of follow-up. Women with stage III–IV symptomatic prolapse were approached consecutively from 2008 to 2013 at one tertiary hospital. The main outcome measure was symptomatic failure. Secondary outcomes included anatomic failure, recurrence, patient satisfaction, complications, and reoperation. The Kaplan-Meier curve was used to estimate the cumulative failure rate. Of the 121 patients enrolled in the study, 103 (85.1%) completed a median follow-up of 11 years. The estimated probability rates of symptomatic and anatomic failure were 17.6% and 8.8% in 11 years, respectively. The estimated incidence of symptomatic failure increased by 8.2% between 5 and 11 years; however, the corresponding rate for anatomic failure was 3.7%. The most common complication was vaginal mesh exposure, and its estimated probability increased from 19.3% to 28.4% from 5 to 11 years, respectively. Office trimming resolved 80.0% of vaginal exposures. These patients did not report decreased overall satisfaction. Patients with vaginal mesh exposure requiring>3 office procedures or mesh removal in the operating room (5.8% by 11 years) had lower satisfaction rates (P<0.01) and were defined as having severe mesh exposure. The rates of postoperative pain, reoperation, and Patient Global Impression of Improvement ⩾2 were 2.5%, 3.3%, and 94.2%, respectively. The results of this study implied that TVM treatment gradually increased the symptomatic failure rate but provided durable anatomical support of the vaginal wall. Vaginal mesh exposure was common in women who were largely not sexually active; however, 80% of the cases could be managed in the outpatient clinic, which did not affect patient satisfaction.
引用
收藏
页码:1061 / 1068
页数:7
相关论文
共 185 条
  • [1] Allègre L(2019)Pelvic Organ Prolapse: ACOG practice bulletin, number 214 Obstet Gynecol 134 e126-e142
  • [2] Callewaert G(2020)Long-term outcomes of a randomized controlled trial comparing trans-obturator vaginal mesh with native tissue repair in the treatment of anterior vaginal wall prolapse Int Urogynecol J 31 745-753
  • [3] Alonso S(2011)Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse N Engl J Med 364 1826-1836
  • [4] Cornille A(1996)The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction Am J Obstet Gynecol 175 10-17
  • [5] Fernandez H(2021)Intermediate- to long-term outcomes of transvaginal mesh for treatment of Asian women with pelvic organ prolapse Hong Kong Med J 27 413-421
  • [6] Eglin G(2013)Indications, contraindications, and complications of mesh in surgical treatment of pelvic organ prolapse Clin Obstet Gynecol 56 276-288
  • [7] de Tayrac R(2017)Mesh, graft, or standard repair for women having primary transvaginal anterior or posterior compartment prolapse surgery: two parallel-group, multicentre, randomised, controlled trials (PROSPECT) Lancet 389 381-392
  • [8] Altman D(2008)Is there a pelvic organ prolapse threshold that predicts pelvic floor symptoms? Am J Obstet Gynecol 199 683.e1-683.e7
  • [9] Väyrynen T(2011)An international urogynecological association (IUGA)/international continence society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic floor surgery Neurourol Urodyn 30 2-12
  • [10] Engh ME(2016)Long-term outcome after transvaginal mesh repair of pelvic organ prolapse Int Urogynecol J 27 1069-1074